Alcon AG (ALC) - Total Assets
Based on the latest financial reports, Alcon AG (ALC) holds total assets worth CHF31.53 Billion CHF (≈ $39.87 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Alcon AG - Total Assets Trend (2015–2025)
This chart illustrates how Alcon AG's total assets have evolved over time, based on quarterly financial data. Also see Alcon AG stock valuation for the company's overall valuation and market capitalisation.
Alcon AG - Asset Composition Analysis
Current Asset Composition (December 2025)
Alcon AG's total assets of CHF31.53 Billion consist of 20.4% current assets and 79.6% non-current assets. Review debt load of Alcon AG to assess the company's total debt and financial obligations.
| Asset Category | Amount (CHF) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF0.00 | 4.8% |
| Accounts Receivable | CHF2.17 Billion | 6.9% |
| Inventory | CHF2.39 Billion | 7.6% |
| Property, Plant & Equipment | CHF0.00 | 0.0% |
| Intangible Assets | CHF9.00 Billion | 28.5% |
| Goodwill | CHF9.25 Billion | 29.3% |
Asset Composition Trend (2015–2025)
This chart illustrates how Alcon AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See ALC live share price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Alcon AG's current assets represent 20.4% of total assets in 2025, an increase from 10.6% in 2015.
- Cash Position: Cash and equivalents constituted 4.8% of total assets in 2025, up from 1.0% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 57.0% of total assets, a decrease from 76.0% in 2015.
- Asset Diversification: The largest asset category is goodwill at 29.3% of total assets.
Alcon AG Competitors by Total Assets
Key competitors of Alcon AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥2.42 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
Visco Vision Inc.
TW:6782
|
Taiwan | NT$5.82 Billion |
|
QITIAN Technology Group Co Ltd
SHE:300061
|
China | CN¥1.17 Billion |
|
Embecta Corp
NASDAQ:EMBC
|
USA | $1.27 Billion |
Alcon AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.12 | 2.77 | 2.53 |
| Quick Ratio | 1.33 | 1.77 | 1.67 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CHF3.40 Billion | CHF4.03 Billion | CHF3.00 Billion |
Alcon AG - Advanced Valuation Insights
This section examines the relationship between Alcon AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.78 |
| Latest Market Cap to Assets Ratio | 0.95 |
| Asset Growth Rate (YoY) | 3.9% |
| Total Assets | CHF31.53 Billion |
| Market Capitalization | $30.03 Billion USD |
Valuation Analysis
Near Book Valuation: The market values Alcon AG's assets close to their book value (0.95x), suggesting investors view the company's assets at approximately fair value.
Positive Asset Growth: Alcon AG's assets grew by 3.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Alcon AG (2015–2025)
The table below shows the annual total assets of Alcon AG from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CHF31.53 Billion ≈ $39.87 Billion |
+3.91% |
| 2024-12-31 | CHF30.35 Billion ≈ $38.37 Billion |
+2.48% |
| 2023-12-31 | CHF29.61 Billion ≈ $37.44 Billion |
+1.39% |
| 2022-12-31 | CHF29.21 Billion ≈ $36.93 Billion |
+4.32% |
| 2021-12-31 | CHF28.00 Billion ≈ $35.40 Billion |
+1.45% |
| 2020-12-31 | CHF27.60 Billion ≈ $34.89 Billion |
-0.20% |
| 2019-12-31 | CHF27.66 Billion ≈ $34.96 Billion |
+1.30% |
| 2018-12-31 | CHF27.30 Billion ≈ $34.52 Billion |
-0.32% |
| 2017-12-31 | CHF27.39 Billion ≈ $34.63 Billion |
-1.27% |
| 2016-12-31 | CHF27.74 Billion ≈ $35.07 Billion |
-1.64% |
| 2015-12-31 | CHF28.20 Billion ≈ $35.65 Billion |
-- |
About Alcon AG
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other product… Read more